This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Ballot Status: Informative | Compartments: Patient, Practitioner |
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped (id = "meddisp0317")
<MedicationDispense xmlns="http://hl7.org/fhir"> <id value="meddisp0317"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative with Details</b> </p> <p> <b> id</b> : meddisp0317</p> <p> <b> contained</b> : </p> <p> <b> status</b> : stopped</p> <p> <b> medication</b> : Brentixumab Vedotin (Adcetris). Generated Summary: id: med0306; Adcetris (Brentuximab Vedotin 50mg/10.5ml) <span> (Details : {http://hl7.org/fhir/sid/ndc code '51144-050-01' = '51144-050-01', given as 'Adcetris (Brentuximab Vedotin 50mg/10.5ml)'})</span> ; Lyophilized powder for injectable solution (qualifier value) <span> (Details : {SNOMED CT code '421637006' = 'Lyophilised powder for injectable solution', given as 'Lyophilized powder for injectable solution (qualifier value) '})</span> </p> <p> <b> subject</b> : <a> Donald Duck </a> </p> <h3> Performers</h3> <table> <tr> <td> -</td> <td> <b> Actor</b> </td> </tr> <tr> <td> *</td> <td> <a> Practitioner/f006</a> </td> </tr> </table> <p> <b> authorizingPrescription</b> : <a> MedicationRequest/medrx0316</a> </p> <p> <b> type</b> : Trial Fill <span> (Details : {http://hl7.org/fhir/v3/ActCode code 'TF' = 'Trial Fill', given as 'Trial Fill'})</span> </p> <p> <b> quantity</b> : 3 415818005<span> (Details: SNOMED CT code 415818005 = '415818005')</span> </p> <p> <b> daysSupply</b> : 1 Day<span> (Details: UCUM code d = 'd')</span> </p> <p> <b> whenPrepared</b> : 25/06/2015 7:13:00 AM</p> <p> <b> whenHandedOver</b> : 26/06/2015 7:13:00 AM</p> <p> <b> dosageInstruction</b> : </p> </div> </text> <contained> <Medication> <id value="med0306"/> <code> <coding> <system value="http://hl7.org/fhir/sid/ndc"/> <code value="51144-050-01"/> <display value="Adcetris (Brentuximab Vedotin 50mg/10.5ml)"/> </coding> </code> <manufacturer> <reference value="Organization/mmanu"/> </manufacturer> <form> <coding> <system value="http://snomed.info/sct"/> <code value="421637006"/> <display value="Lyophilized powder for injectable solution (qualifier value) "/> </coding> </form> </Medication> </contained> <status value="stopped"/> <medicationReference> <!-- Linked to a RESOURCE Medication --> <reference value="#med0306"/> <display value="Brentixumab Vedotin (Adcetris)"/> </medicationReference> <subject> <reference value="Patient/pat1"/> <display value="Donald Duck "/> </subject> <performer> <actor> <reference value="Practitioner/f006"/> </actor> </performer> <authorizingPrescription> <reference value="MedicationRequest/medrx0316"/> </authorizingPrescription> <type> <coding> <system value="http://hl7.org/fhir/v3/ActCode"/> <code value="TF"/> <display value="Trial Fill"/> </coding> </type> <quantity> <value value="3"/> <system value="http://snomed.info/sct"/> <code value="415818005"/> </quantity> <daysSupply> <value value="1"/> <unit value="Day"/> <system value="http://unitsofmeasure.org"/> <code value="d"/> </daysSupply> <whenPrepared value="2015-06-25T07:13:00+05:00"/> <whenHandedOver value="2015-06-26T07:13:00+05:00"/> <dosageInstruction> <sequence value="1"/> <text value="1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles"/> <timing> <repeat> <count value="16"/> <frequency value="1"/> <period value="3"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="255560000"/> <display value="Intravenous"/> </coding> </route> <doseQuantity> <value value="1.8"/> <unit value="mg/kg"/> <system value="http://unitsofmeasure.org"/> <code value="mg/kg"/> </doseQuantity> </dosageInstruction> </MedicationDispense>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.